deCODE reborn
A leaner version of the failed Icelandic genomics company, deCODE genetics, has emerged from the corporation's bankruptcy late last year. Dubbed the "New deCODE" in a company linkurl:statement;https://www.decode.com/news/news.php?story=112 released today (Jan 21), deCODE genetics ehf will focus less on in-house drug discovery, instead partnering with drug makers to translate its genetic discoveries into therapies. The new company will also continue to sell its diagnostics disease risk tests and i
Written byBob Grant
| 1 min read
Register for free to listen to this article
Listen with Speechify
0:00
1:00
**__Related stories:__***linkurl:deCODE files for bankruptcy;https://www.the-scientist.com/blog/display/56152/
[17th November 2009]*linkurl:deCODE close to broke;https://www.the-scientist.com/blog/display/55884/
[11th August 2009]*linkurl:deCODE falls from NASDAQ grace;https://www.the-scientist.com/blog/display/55200/
[18th November 2008]
Interested in reading more?
The Scientist ARCHIVES
Become a Member of
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here
Add The Scientist as a preferred Google source to see more of our trusted coverage.
Meet the Author
From 2017 to 2022, Bob Grant was Editor in Chief of The Scientist, where he started in 2007 as a Staff Writer. Before joining the team, he worked as a reporter at Audubon and earned a master’s degree in science journalism from New York University. In his previous life, he pursued a career in science, getting a bachelor’s degree in wildlife biology from Montana State University and a master’s degree in marine biology from the College of Charleston in South Carolina. Bob edited Reading Frames and other sections of the magazine.
View Full Profile
